Why is SCNI stock up today?
In plain English
The only news (“Scinai Immunotherapeutics to Lead Strategic Roundtable Dis…”) is stale (122d old) — too old to explain today's move. Likely momentum, not news.
What it means for you
Choppy and directionless — no clear pattern in either direction. Risk level: moderate.
About Scinai Immunotherapeutics Ltd. American Depositary Shares
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early
See it in context
SCNI opened +40.4% versus the prior close, then finished +4.7% from its open, on 41.1M shares traded.
Against the whole market that day, 35.0% of US stocks closed higher (median move -0.2%) — so SCNI rose even as most stocks fell. See the full market recap →
More movers: today's biggest gainers · today's biggest gap-ups · all screeners · why other stocks are moving
Learn the basics: how to read a chart · what volume means · grade SCNI’s chart with the AI reader →